Regulatory Intelligence: Not the Best Tool, but the Right Fit

The question of which regulatory intelligence platform is the best is raised early in selection projects and almost always answered incorrectly. There is no universally best solution, only the one that fits a specific organisation, its processes and its regulatory context. It is precisely this confusion between range of features and fit that causes most implementations to fail.

Three Patterns That Regularly Cause Tool Selection to Fail

In practice, three mistakes recur, regardless of vendor and price category:

• Selection based on feature lists. Tools are assessed against feature catalogues and vendor promises before the organisation's own regulatory context and structure have even been defined. The selection therefore answers a question that nobody asked.
• Regulatory intelligence as an isolated solution. Without a connection to quality management, post-market surveillance and clinical processes, silos arise instead of strategic intelligence. The platform gathers information that no one translates into a decision.
• Volume over decision quality. The focus lies on the volume of regulatory updates collected, not on the quality of the decisions that should result from them. More notifications produce more noise, not more clarity.

Four Dimensions That Actually Decide the Outcome

A viable RI setup does not begin with a feature list, but with four questions of fit:

• Context before range of features. What matters is not what the platform can do, but what the organisation actually needs. A powerful platform without organisational fit is a burden, not an advantage.
• Integration before isolation. If the tool is not connected to QMS, post-market surveillance and clinical processes, data silos arise. The riskiest setups are those that work as islands and do not feed their findings back into operational systems.
• Scalability before quick wins. What works today must also hold up when the portfolio grows or the regulatory landscape evolves. MDR (EU 2017/745), IVDR (EU 2017/746) and the EU AI Act (EU 2024/1689) are not static targets but keep moving.
• Interpretation before information. Data is available everywhere. The real task is to derive from a regulatory notification a consequence relevant to action for the product, market and timing. The value of regulatory intelligence lies in the quality of the decisions, not in the size of the database.

How to Recognise a Viable RI Setup

A good regulatory intelligence system is not evident from the number of subscribed sources, but from the fact that a relevant change to MDR, IVDR or a harmonised standard reliably reaches the person who has to act on it, with the necessary interpretation and without a manual media break. It filters what is relevant out of the noise, assigns it to the affected product or process and makes it clear which decision follows from it.

How Entourage Supports You

We do not start with the tool, but with the organisation. Together we define what regulatory intelligence has to deliver in the specific setup, both today and over the next three to five years. On this basis we accompany the evaluation and introduction of a solution that fits the processes, team and regulatory context, and we embed it into existing QMS, PMS and clinical workflows without creating new silos. The goal is not more information, but the better regulatory decision: for the right product, in the right market, at the right time.